Jan Borysowski

16PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersMolecular targetsRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Mar 31, 2026
The use of endpoints in phase 3 randomized controlled trials in metastatic breast cancer.

Weronika Kupis, Danuta Kłosowska, Marek Harhala

|Mar 16, 2026
Eligibility criteria in phase 3 randomized controlled trials in metastatic non-small cell lung cancer.

Jan Borysowski, Danuta Kłosowska, Marek Harhala

|Nov 06, 2025
Exclusion of patients with renal impairment from phase 3 randomized controlled trials in hematologic malignancies.

Danuta Kłosowska, Michał Ordak, Ewa Lech-Marańda

|Sep 11, 2025
Eligibility criteria in phase 3 randomized controlled trials in gastric cancer.

Katarzyna Marcisz-Grzanka, Danuta Kłosowska, Marek Harhala

|Dec 26, 2024
Exclusion of older persons from randomized controlled trials in type 2 diabetes: A cross-sectional study.

Jan Borysowski, Danuta Kłosowska, Leszek Pączek

|May 27, 2023
Exclusion of older adults from randomized controlled trials in rheumatoid arthritis.

Anna Mańko, Anna Raczkiewicz, Andrzej Górski

Pageof 3